PR: Heidelberg Pharma AG: Partner Telix Pharmaceuticals Files Phase III Trial for Kidney Cancer Imaging in Europe
- PDF File: images/files/press-releases-and-ad-hoc-announcements/2021/20180823_heidelberg-pharma_pr_telix_ph-iii_eng_final.pdf
- Datum: Thursday, 23 August 2018 10:44
- Erstellt am .
- Geändert am .
- Aufrufe: 1297